Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza (Healthy Volunteers)”

257 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 257 results

Large-scale testing (Phase 3)Looking for participantsNCT07365826
What this trial is testing

A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age

Who this might be right for
Pneumococcal Vaccines
Vaxcyte, Inc. 1,300
Testing effectiveness (Phase 2)Study completedNCT01393951
What this trial is testing

Evaluate the Immune Response to the ASP7374 and Its Safety in Healthy Adult Volunteers

Who this might be right for
HealthyImmunogenicity of ASP7374
UMN Pharma Inc. 165
Early research (Phase 1)Study completedNCT02377401
What this trial is testing

Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults

Who this might be right for
Influenza, Human
GlaxoSmithKline 24
Post-approval studies (Phase 4)Study completedNCT00888381
What this trial is testing

Assess the Immunogenicity and Safety of CSL's 2009 / 2010 Formulation of Enzira® Vaccine in Healthy Volunteers

Who this might be right for
Influenza
Seqirus 120
Large-scale testing (Phase 3)Study completedNCT01755364
What this trial is testing

A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old

Who this might be right for
Influenza
Adimmune Corporation 122
Early research (Phase 1)Study completedNCT04982913
What this trial is testing

Single Dose and Multiple Dose Safety, Tolerability, PK，and Food Effect Study，and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects

Who this might be right for
Influenza
Sunshine Lake Pharma Co., Ltd. 118
Testing effectiveness (Phase 2)Study completedNCT05519839
What this trial is testing

Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine

Who this might be right for
COVID-19Influenza
Novavax 1,579
Not applicableStudy completedNCT01007201
What this trial is testing

Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric Population

Who this might be right for
Influenza
Adimmune Corporation 183
Large-scale testing (Phase 3)Study completedNCT00971100
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 752
Early research (Phase 1)Study completedNCT05027932
What this trial is testing

Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 45
Post-approval studies (Phase 4)Study completedNCT01863433
What this trial is testing

Assess the Immunogenicity and Safety of a Trivalent Influenza Vaccine Containing the 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers

Who this might be right for
Influenza, Human
Seqirus 120
Testing effectiveness (Phase 2)Ended earlyNCT00383071
What this trial is testing

Development of Immune Globulin Treatment for Avian Flu

Who this might be right for
Infectious DiseasesInfluenzaAvian Flu
National Institute of Allergy and Infectious Diseases (NIAID) 126
Early research (Phase 1)UnknownNCT04674709
What this trial is testing

Evaluation of the Safety and Pharmacokinetics of Oleander 4X in Healthy Volunteers

Who this might be right for
Flu-like Symptoms
Avila Herbals 75
Early research (Phase 1)Study completedNCT01181336
What this trial is testing

Phase 1b Influenza Vaccine Study in Healthy Subjects

Who this might be right for
Influenza
PepTcell Limited 48
Early research (Phase 1)Study completedNCT00408109
What this trial is testing

Safety Study of Avian Flu Vaccine

Who this might be right for
Influenza A Virus, H5N1 SubtypeInfluenza A VirusInfluenzavirus A+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 45
Early research (Phase 1)Study completedNCT01333462
What this trial is testing

Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008

Who this might be right for
Healthy Adult Volunteers
NanoBio Corporation 199
Early research (Phase 1)Study completedNCT00489931
What this trial is testing

Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally

Who this might be right for
Influenza A Virus, H5N1 SubtypeInfluenza A VirusInfluenzavirus A+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 44
Testing effectiveness (Phase 2)Study completedNCT01224262
What this trial is testing

A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001

Who this might be right for
Influenza
Liquidia Technologies, Inc. 152
Post-approval studies (Phase 4)Study completedNCT03163342
What this trial is testing

Immune Response Following Seasonal Influenza Vaccination

Who this might be right for
Influenza
Altimmune, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT02468115
What this trial is testing

Influenza Challenge Study of VIS410 in Healthy Volunteers

Who this might be right for
Influenza
Visterra, Inc. 46
Load More Results